AZD1981

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2016
01220112016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
AIM AZD1981 is an orally bioavailable chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) receptor… (More)
Is this relevant?
Review
2017
Review
2017
The introduction of omalizumab to the management of chronic spontaneous urticaria (CSU) has markedly improved the therapeutic… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2016
2016
BACKGROUND Chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cell (CRTh2) receptor antagonists is… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
OBJECTIVE To evaluate the efficacy and tolerability of the selective CRTh2 (DP2) receptor antagonist AZD1981 compared with… (More)
Is this relevant?
2013
2013
BACKGROUND AND PURPOSE The discovery of DP2 as a second receptor for PGD2 has prompted the search for antagonists as potential… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2011
2011
Novel indole-3-thio-, 3-sulfonyl- and 3-oxy-aryl-1-acetic acids are reported which are potent, selective antagonists of the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 2
Is this relevant?